AnnMohrbacherMD

Associate Professor, Medicine, USC School of Medicine

Dr. Mohrbacher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1441 Eastlake Ave
Ste 8302E
Los Angeles, CA 90089
Phone+1 323-442-5100

Fax+1 323-442-5641

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1993
Brigham and Women's HospitalResidency, Internal Medicine, 1987 - 1990
Harvard Medical SchoolClass of 1987

PubMed

2 citations
Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial.
Steffan T Nawrocki, Julian Olea, Claudia Villa Celi, Homa Dadrastoussi, Kaijin Wu
Clinical Cancer Research. 2023-12-15
2 citations
Secondary haematologic malignancies in women with ovarian cancer receiving poly-ADP ribose polymerase inhibitor therapy.
Koji Matsuo, Maximilian Klar, Ann Mohrbacher, Lynda D. Roman, Jason D. Wright
European Journal of Cancer. 2021-09-03
7 citations
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States
Yang Yu, Niquelle Brown Wadé, Amie E. Hwang, Ajay K. Nooka, Mark A. Fiala
JCO Oncology Practice. 2020-05-29

Abstracts/Posters

Comprehensive Investigation of White Blood Cell and Gene Expression Profiles As Risk Factors for Multiple Myeloma in African Americans
Ann Mohrbacher, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019